Axitinib and Ipilimumab for Advanced Melanoma
Phase 2
25
about 5.7 years
18+
1 site in FL
What this study is about
This trial is testing if taking axitinib with ipilimumab is effective in treating advanced melanoma. The treatment involves medication. Adults will be enrolled, and its length is 2063 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Axitinib
- 2.Take Ipilimumab
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
axitinib, ipilimumab (Immune checkpoint inhibitor; blocks CTLA-4 on T cells)
oral (Oral Tablet), injection (Injection)
Primary: Overall Response Rate
Secondary: Clinical Benefit Rate, Duration of Response, Overall Survival, Progression Free Survival
Oncology